Please provide your email address to receive an email when new articles are posted on . Risk for type 2 diabetes and atherosclerotic CVD varies across Asian American subgroups. Providers should ...

Genetic and epidemiological evidence indicates that triglyceride-rich lipoproteins are causal risk factors for atherosclerotic cardiovascular disease (ASCVD). Elevated levels of plasma triglyceride ...

Researchers found that the cumulative incidence of MI, stroke, and 10-year all-cause mortality was significantly lower in the ASA group vs the no-ASA group (42.4 vs 61.2%, 14.5 vs 24.8%, and 33 vs ...

The drug was as good as a proven GLP-1, giving doctors another potent option for patients with type 2 diabetes and ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Finerenone was beneficial in primary and secondary prevention across the spectrum of patients with ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Different ...

The authors noted that until recently, medications to control blood glucose were not expected to offer any benefit in helping patients avoid cardiovascular events. A new American College of Cardiology ...

The AHA/ACC published a new clinical practice guideline on managing cholesterol and provided a risk assessment report on primary prevention of ASCVD. The American Heart Association (AHA) and the ...

VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.